Uveitis is an inflammatory condition that affects the uvea, the layer of tissue composed largely of blood vessels that support and deliver nutrients to many important parts of the eye, including the light-sensing retina. When a patient contracts uveitis, inflammation can become so severe that it interferes with the function of these blood vessels. At Retina Specialty Institute, patients diagnosed with uveitis will undergo immediate treatment to reduce inflammation.
Symptoms of Uveitis
If you feel that you may be suffering from uveitis, be on the lookout for the following symptoms and, should you be experiencing any of these, seek eye treatment with your trusted team of eye doctors:
- Blurred vision
- Eye pain
- Light sensitivity
- Redness of the eye
- Floaters or spots in your vision
- Headaches
- Changed color of the iris
How Our Specialists Treat Uveitis
Uveitis can sometimes appear as a result of eye trauma, or as a symptom of an underlying disease or infection, so patients are subject to a comprehensive eye exam and full review of medical history before diagnosis. These results alongside an x-ray and blood test will help the doctor determine your treatment.
Uveitis can cause permanent damage to the eye if left untreated, including vision loss, so treatment will begin immediately upon diagnosis. Corticosteroids are used to reduce the swelling of the eye and maybe delivered via eye drops or injections. In serious cases, oral or intravenous medications will need to be administered to quickly and drastically reduce inflammation.
Contact Southern Eye Group
Whether you’re simply due for a routine checkup or are suffering from an eye injury, schedule an appointment at one of our 13 locations. Our expert team will evaluate you and develop a treatment plan to address your needs. We have offices across Florida and Alabama, as well as an office in Biloxi, Mississippi. Call us at 1-855-573-8462, or contact us online, we can’t wait to meet you!
The doctors at Retina Specialty Institute have either authored or reviewed and approved this content.
Page Updated:
